Genetics and susceptibility to human papillomaviruses: Epidermodysplasia verruciformis, a model disease;Génétique et sensibilité aux papillomavirus: Le modèle de l'épidermodysplasie verruciforme

Bulletin de l'Academie Nationale de Medecine

Volumn 194, Issue 6, 2010, Pages 923-941

  Orth, Gérard ^a  

^a INSTITUT PASTEUR   (France)

Author keywords

Carcinoma; Epidermodysplasia Verruciformis; Genetic Predisposition To Disease; Keratinocytes; Papillomavirus Infections

Indexed keywords

EID: 79952049718     PISSN: 00014079     EISSN: None     Source Type: Journal    
DOI: 10.1016/s0001-4079(19)32253-8     Document Type: Article

References (71)

1. HOWLEY P.M., LOWY D.R. -Papillomaviruses. In KNIPE D.M., HOWLEY P.M., GRIFFIN D.E., LAMB R.A., MARTIN M.A., ROIZMAN B. et al. (ed.) Fields Virology, 2007, Wolters Kluwer/Lippincott Williams and Wilkins, Philadelphia, PA, pp 2229-2354.
2. rd edn., vol. 4, Oxford, Elsevier, 2008, pp. 8-18.
3. BOSCH F.X., LORINCZ A., MUNOZ N., MELIER C.J., SHAH K.V. -The causal relation between human papillomavirus and cervical cancer. J. Clin. Pathol, 2002, 55, 244-265.
4. SCHIFFMAN M., KJAER S.K. -Natural history of anogenital human papillomavirus infection and neoplasia. J. Natl. Cancer Inst. Monogr. 2003, 31, 14-19.
5. STANLEY M. -Immune responses to human papillomavirus. Vaccine, 2006, 24, S16-S22.
6. ORTH G. -Genetics of epidermodysplasia verruciformis: insights into host defense against papillomaviruses. Semin. Immunol, 2006, 75, 362-374.
7. ORTH G. -Host defenses against human papillomaviruses : lessons from epidermodysplasia verruciformis. Curr. Top. Microbiol. Immunol, 2008, 321, 59-83.
8. LAZARCZYK M., CASSONNET P., PONS C., JACOB Y., FAVRE M. -The EVER proteins as a natural barrier against papillomaviruses: a new insight into the pathogenesis of human papillomavirus infections. Microbiol. Mol. Biol. Rev., 2009, 73, 348-370.
9. BERNARD H.U., BURK R.D., CHEN Z., VAN DOORSLAER K., ZUR HAUSEN H., DE VILLIERS E.M. - Classification of papillomaviruses (PVs) based on 189 PV types and proposal of taxonomic amendments. Virology, 2010, 401, 70-79.
10. BLANPAIN C., FUCHS E. -Epidermal homeostasis: a balancing act of stem cells in the skin. Nat. Rev. Mol. Cell Biol, 2009, 10, 207-217.
11. MÜNGER K., BALDWIN A., EDWARDS K.M., HAYAKAWA H., NGUYEN C.L., OWENS M. et al. Mechanisms of human papillomavirus-induced oncogenesis. J. Virol. 2004, 78, 11451-11460.
12. WOODWORTH C.D. -HPV innate immunity. Front. Biosci., 2002, 7, 2058-2071.
13. FRAZER I.H., THOMAS R., ZHOU J., LEGGATT G.R., DUNN L., MCMILLAN N. et al. -(1999) Potential strategies utilised by papillomavirus to evade host immunity. Immunol. Rev., 1999, 168, 131-142.
14. HERNANDEZ P.A., GORLIN R.J., LUKENS J.N., TANIUCHI S., BOHINJEC J., FRANÇOIS F. et al. Mutations in the chemokine receptor gene CXCR4 are associated with WHIM syndrome, a combined immunodeficiency disease. Nat. Genet., 2003, 34, 70-74.
15. BEAUDENON S., PRAETORIUS F., KREMSDORF D., LUTZNER M., WORSAAE N., PEHAU-ARNAUDET G. et al. -A new type of human papillomavirus associated with oral focal epithelial hyperplasia. J. Invest. Dermatol., 1987, 55, 130-135.
16. HILDESHEIM A., WANG S.S. -Host and viral genetics and risk of cervical cancer: a review. Virus Res., 2002, 89, 229-240.
17. WANG S.S., GONZALES P., YU K., PORRAS C., LI Q., SAFAEIAN M. et al. -Common genetic variants and risk for persistence and progression to cervical cancer. PLoS One, 2010, 5, e8667.
18. SOUSA H., SANTOS A.M., PINTO D., MEDEIROS R. -Is the p53 codon 72 polymorphism a key biomarker for cervical cancer development? A meta-analysis review within European populations. Int. J. Mol. Med., 2007, 20, 731-741.
19. LEWANDOWSKY F., LUTZ W. -Ein Fall einer bisher nicht beschriebenen Hauterkrankung (Epidermodysplasia verruciformis). Arch. Dermatol. Syphilol, 1922, 141, 193-203.
20. COCKAYNE E.A. -Inherited abnormalities of the skin and its appendages. Oxford University London, 1933, p. 156.
21. ORTH, G. -Epidermodysplasia verruciformis. In: Howley PM, Salzman NP (eds) The papovaviridae. Plenum publishing Corporation, 1987, pp 199-243.
22. LUTZ W.A. -A propos de l'épidermodysplasie verruciforme. Dermatológica, 1946, 92, 30-43.
23. JABLONSKA S., DABROWSKI J., JAKUBOWICZ K. -Epidermodysplasia verruciformis as a model in studies on the role of papovaviruses in oncogenesis. Cancer Res., 1972, 32, 583-589.
24. PASS F., REISSIG M., SHAH K. V., EISINGER M., ORTH G. -Identification of an immunologically distinct papillomavirus from lesions of epidermodysplasia verruciformis. J. Natl. Cancer Inst., 1977, 59, 1107-1112.
25. ORTH G., JABLONSKA S., FAVRE M., CROISSANT O., JARZABEK-CHORZELSKA M., RZESA G. Characterization of two types of human papillomaviruses in lesions of epidermodysplasia verruciformis. Proc. Natl. Acad Sci. U. S. A., 1978, 75, 1537-1541.
26. ORTH G., JABLONSKA S., JARZABEK-CHORZELSKA M., RZESA G., OBALEK S., FAVRE M. et al. Characteristics of the lesions and risk of malignant conversion as related to the type of the human papillomavirus involved in epidermodysplasia verruciformis. Cancer Res., 1979, 39, 1074-1082.
27. ORTH G., FAVRE M., BREITBURD F., CROISSANT O., JABLONSKA S., OBALEK S. et al. Epidermodysplasia verruciformis : a model for the role of papillomaviruses in human cancer. Cold Spring Harbor Conf. Cell Prolif, 1980, 7, 259-282.
28. BOXMAN I.L.A., BERKHOUT R.J.M., MULDER L.H.C., WOLKERS M.C., BOUWES BAVINCK J.N, VERMEER B.J. et al. -Detection of human papillomavirus DNA in plucked hairs from renal transplant recipients and healthy volunteers. J. Invest. Dermatol, 1997, 108, 712-715.
29. ASTORI G., LAVERGNE D., BENTON C., HOCKMAYR B., EGAWA K., GARBE C et al. -Human papillomaviruses are commonly found in normal skin of immunocompetent hosts. J. Invest. Dermatol, 1998, 110, 752-755.
30. ANTONSSON A., FORSLUND O., EKBERG H., STERNER G., HANSSON B.G. -The ubiquity and impressive genomic diversity of human skin papillomaviruses suggest a commensalic nature of these viruses. J. Virol., 2000, 74, 11636-11641.
31. RAMOZ N., TAIEB A., RUEDA L.A., MONTOYA L.S., BOUADJAR B., FAVRE M. et al. -Evidence for a nonallelic heterogeneity of epidermodysplasia verruciformis with two susceptibility loci mapped to chromosome regions 2p21-p24 and 17q 25. J. Invest. Dermatol., 2000, 114, 1148-1153.
32. RAMOZ N., RUEDA L.A., BOUADJAR B., MONTOYA L.S., ORTH G., FAVRE M. -Mutations in two adjacent novel genes are associated with epidermodysplasia verruciformis. Nat. Genet., 2002, 32, 579-581.
33. JABLONSKA S., ORTH G. -Epidermodysplasia verruciformis. Clin. Dermatol, 1985, 3(4), 83-96.
34. LUTZNER M.A. -Epidermodysplasia verruciformis: an autosomal recessive disease characterized by viral warts and skin cancer. A model for viral oncogenesis. Bull. Cancer, 1978, 65, 169-182.
35. PADLEWSKA, K., RAMOZ, N., RIOU, G., BARROIS, M., MAJEWSKI, S., CROISSANT O. et al. Mutation and abnormal expression of the p53 gene in the viral skin carcinogenesis of epidermodysplasia verruciformis. J. Invest. Dermatol, 20001, 117, 935-942.
36. FAVRE M., ORTH G., MAJEWSKI S., BALOUL S., PURA A., JABLONSKA S. -Psoriasis: a possible reservoir for human papillomavirus type 5, the virus associated with skin carcinomas of epidermodysplasia verruciformis. J. Invest. Dermatol, 1998, 110, 311-317.
37. MICHAEL K.M., WATERBOER T., PFISTER H., GARIGLIO M., MAJEWSKI S., FAVRE M. et al. Seroreactivity of 38 Human papillomavirus types in epidermodysplasia verruciformis patients, relatives, and controls. J. Invest. Dermatol, 2010, 130, 841-848.
38. TAGAMI H., AIBA S., ROKUGO M. -Regression of flat warts and common warts. Clin. Dermatol., 1985, 3(4), 170-178.
39. MAJEWSKI S., JABLONSKA S., ORTH G. -Epidermodysplasia verruciformis. Immunological and nonimmunological surveillance mechanisms: role in tumor progression. Clin. Dermatol., 1997, 15, 321-334
40. GLINSKI W., JABLONSKA S., LANGNER A., OBALEK S., HAFTEK M., PRONIEWSKA M. -Cellmediated immunity in epidermodysplasia verruciformis. Dermatologica, 1976, 153, 218-227.
41. OLIVEIRA W.R.P., CARRASCO S., NETO C.F., RADY P., TYRING S.K. -Nonspecific cellmediated immunity in patients with epidermodysplasia verruciformis. J. Dermatol., 2003, 30, 203-209.
42. LUTZNER M.A., ORTH G., DUTRONQUAY V., DUCASSE M-F., KREIS H., CROSNIER J. -Detection of human papillomavirus type 5 DNA in skin cancers of an immunosuppressed renal allograft recipient. Lancet, 1983, 2, 422-424.
43. ROGERS H.D., MACGREGOR J.L., NORD K.M., TYRING S., RADY, P., ENGLER, D.E. et al. Acquired epidermodysplasia verruciformis. J. Am. Acad. Dermatol. 2009, 60, 315-320.
44. OBALEK S., FAVRE M., SZYMANCZYK J., MISIEWICZ J., JABLONSKA S., ORTH G. -Human papillomavirus (HPV) types specific of epidermodysplasia verruciformis detected in warts induced by HPV3 or HPV3-related types in immunosuppressed patients. J. Invest. Dermatol., 1992, 95, 936-941.
45. LAFFORT C., LE DEIST F., FAVRE M., CAILLAT-ZUCMAN S., RADFORD-WEISS I., DEBRÉ M. et al. - Severe cutaneous papillomavirus disease after haemopoietic stem-cell transplantation in patients with severe combined immune deficiency caused by common gamma cytokine receptor subunit or JAK-3 deficiency. Lancet, 2004, 363, 2051-2054.
46. FAVRE M., MAJEWSKI S., NOSZCZYK B., MAIENFISCH F., PURA A., ORTH G. et al. -Antibodies to human papillomavirus type 5 are generated in epidermal repair processes. J. Invest. Dermatol, 2000, 114, 403-407.
47. ORTH G. -Human papillomaviruses associated with epidermodysplasia verruciformis in non-melanoma skin cancers: guilty or innocent? J. Invest. Dermatol, 2005, 125, xii-xiii.
48. PFISTER H. -Human papillomavirus and skin cancer. J. Natl. Cancer Inst. Monogr., 2003, 31, 52-56.
49. KAWASHIMA M., FAVRE M., OBALEK S., JABLONSKÁ S., ORTH G. -Premalignant lesions and cancers of the skin in the general population: evaluation of the role of human papillomaviruses. J Invest Dermatol., 1990, 95, 537-542.
50. KARAGAS M.R., NELSON H.H., SEHR P., WATERBOER T., STUKEL T.A, ANDREW A. et al. Human papillomavirus infection and incidence of squamous cell and basal cell carcinomas of the skin. J. Natl. Cancer Inst., 2006, 95, 389-395.
51. STOREY A. -Papillomaviruses: death-defying acts in skin cancer. Mol. Med., 2002, 8, 417-421.
52. MAJEWSKI S., JABLONSKA S., FAVRE M., RAMOZ N., ORTH G. -Papillomavirus and autoimmunity in psoriasis. Immunol. Today, 1999, 20, 475-476.
53. ANDROPHY E.J., DVORETZKY L, LOWY D.R. -X-linked inheritance of epidermodysplasia verruciformis: genetic and virologie studies of a kindred. Arch. Dermatol, 1985,121, 864-868.
54. RAMOZ N., RUEDA L.A., BOUADJAR B., FAVRE M., ORTH G. -A susceptibility locus for epidermodysplasia verruciformis, an abnormal predisposition to infection with the oncogenic human papillomavirus type 5, maps to chromosome I7qter in a region containing a psoriasis locus. J Invest Dermatol, 1999, 112, 259-263.
55. KURIMA K., YANG Y., SORBER K., GRIFFITH A.J. -Characterization of the transmembrane channel-like (TMC) gene family: functional clues from hearing loss and epidermodysplasia verruciformis. Genomics, 2003, 82, 300-308.
56. LAZARCZYK M., PONS C., MENDOZA J.A., CASSONNET P., JACOB Y., FAVRE M. -Regulation of cellular zinc balance as a potential mechanism of EVER-mediated protection against pathogenesis by cutaneous oncogenic human papillomaviruses. J. Exp. Med., 2008, 205, 35-42.
57. COUSINS R.J., Liuzzi J.P., LICHTEN L.A. -Mammalian zinc transport, trafficking, and signals. J. Biol Chem., 2006, 281, 24085-24089. (Pubitemid 44274182)
58. NONNENMACHER M., SALMON J., JACOB Y., ORTH G., BREITBURD F. -Cottontail rabbit papillomavirus E8 protein is essential for wart formation and provides new insights into viral pathogenesis. J. Virol, 2006, 80, 4890-4900.
59. DIMAIO D, MATTOON D. -Mechanisms of cell transformation by papillomavirus E5 proteins. Oncogene, 2001, 20, 7866-7873.
60. BREITBURD F., NONNENMACHER N., SALMON J., ORTH G. -Rabbit viral papillomas and carcinomas: Model diseases for human papillomavirus infections and associated carcinogenesis, pp.399-420. In Campo S. (ed.), Papillomavirus research: from natural history to vaccines and beyond. Caister Academic Press, Norwich, United Kingdom, 2006.
61. HIRANO T., MURAKAMI M., FUKADA T., NISHIDA K., YAMASAKI S., SUSUKI T. -Roles of zinc and zinc signaling in immunity: zinc as an intracellular signaling molecule. Adv. Immunol., 2008, 97, 149-176.
62. BIENIASZ P.D. -Intrinsic immunity: a front-line defense against viral attack. Nat. Immunol, 2004, 5, 1109-1115.
63. KITAMURA H., MORIKAWA H., KAMON H., IGUCHI M., HOJYO S., FUKADA T. et al. -Toll-like receptor-mediated regulation of zinc homeostasis influences dendritic cell function. Nat. Immunol, 2006, 7, 971-977.
64. RINK L., HAASE H. -Zinc homeostasis and immunity. Trends Immunol, 2006, 28, 1-4.
65. YAMASAKI S., SAKATA-SOGAWA K., HASEGAWA A., SUZUKI T., KABU K., SATO E. et al. -Zinc is a novel intracellular second messenger. J. Cell Biol, 2007, 177, 637-645.
66. Bos J.D. (Ed) -Skin immune system. Cutaneous immunology and clinical Immunodermatology. 2005, 3rd edition, Boca Raton, CRC Press.
67. KUPPER T.S., FUHLBRIGGE R.C. -Immune surveillance in the skin: mechanisms and clinical consequences. Nat. Rev. Immunol, 2004, 4, 211-212.
68. ALCAÏS A., ABEL L., CASANOVA J.L. -Human genetics and infectious diseases: between proof of principle and paradigm. J. Clin. Invest., 2009, 119, 2506-2514.
69. BRUTON O.C - Agammaglobulinemia. Pediatrics, 1952, 9, 722-728.
70. PATEL A.S., KARAGAS M.R., PAWLITA M., WATERBOER T., NELSON H.H. -Cutaneous human papillomavirus infection, the EVER2 gene and incidence of squamous cell carcinoma: a case-control study. Int. J. Cancer, 2008, 122, 2377-2379.
71. AKGÜL B., KOSE O., SAFALI M., PURDIE K., CERIO R., PROBY C. -A distinct variant of Epidermodysplasia verruciformis in a Turkish family lacking EVER1 and EVER2 mutations. Dermatol. Sci, 2007, 46, 214-216.